| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Cefixime Impurity 1 |
頭孢克肟雜質(zhì)1 |
80544-17-8 |
詳細(xì)
|
| Cinchocaine EP Impurity C ;Dibucaine Impurity C) |
辛可卡因EP雜質(zhì)C;地布卡因雜質(zhì)C |
87864-08-2 |
詳細(xì)
|
| Citalopram Dimethylaminobutanone Di-Oxalate ;5-Dimethylaminobutyryl Citalopram Di-Oxalate |
西酞普蘭二甲氨基丁酮迪草酸鹽;5-二甲基氨基丁?；魈仗m二草酸酯 |
|
詳細(xì)
|
| Clindamycin 2,4-Diphosphate |
克林霉素2,4-二磷酸 |
1309048-48-3 |
詳細(xì)
|
| Clopidogrel Related Compound A ;(S)-Clopidogrel Carboxylic Acid |
氯吡格雷相關(guān)化合物A;(S)- 氯吡格雷羧酸 |
144457-28-3 |
詳細(xì)
|
| Dabigatran etexilate Impurity F |
達(dá)比加群酯雜質(zhì)F |
1702936-92-2 |
詳細(xì)
|
| Dasatinib Dimeric Impurity;2,2'-[1,4-Piperazinediylbis[(2-methyl-6,4-pyrimidinediyl)imino]]bis[N-(2-chloro-6-methylphenyl)-5-thiazolecarboxamide |
達(dá)沙替尼二聚體雜質(zhì)2 |
910297-61-9 |
詳細(xì)
|
| Desbenzyl Donepezil;2,3-Dihydro-5,6-dimethoxy-2-(4-piperidinylmethyl)-1H-inden-1-one; 4-[(5,6-Dimethoxy-1-oxoindan-2-yl)methyl]piperidine; 5,6-Dimethoxy-2-[(4-piperidinyl)methyl]-1-indanone; |
脫芐多奈哌齊 |
120014-30-4 |
詳細(xì)
|
| Dibenzo[b,f][1,4]thiazepin-11(10H)-one, 5-oxide |
二苯并[b,f][1,4]硫氮雜卓-11-[10H]酮-5-氧化物 |
20290-48-6 |
詳細(xì)
|
| Domperidone EP Impurity A |
多潘立酮EP雜質(zhì)A |
53786-28-0 |
詳細(xì)
|
| Domperidone EP Impurity B |
多潘立酮EP雜質(zhì)B |
1346598-11-5 |
詳細(xì)
|
| Domperidone EP Impurity E |
多潘立酮EP雜質(zhì)E |
1346602-50-3 |
詳細(xì)
|
| Domperidone EP Impurity F |
多潘立酮EP雜質(zhì)F |
1391053-55-6 |
詳細(xì)
|
| Domperidone Impurity C |
多潘立酮雜質(zhì)C |
118435-03-3 |
詳細(xì)
|
| Donepezil Benzyl Bromide Impurity |
鹽酸多奈哌齊芐基溴 |
844694-85-5 |
詳細(xì)
|
| Donepezil Dehydrodeoxy Impurity |
多奈哌齊脫氫脫氧雜質(zhì) |
120013-45-8 |
詳細(xì)
|
| Doxofylline Impurity 1 |
多索茶堿雜質(zhì)1 |
1429636-74-7 |
詳細(xì)
|
| Doxofylline Impurity 2 |
多索茶堿雜質(zhì)2 |
5614-53-9 |
詳細(xì)
|
| ethyl (1R,2R)-2-(3,4-difluorophenyl)cyclopropane-1-carboxylate |
替卡格雷化合物D |
1006376-61-9 |
詳細(xì)
|
| Fludarabine Phosphate EP Impurity B |
氟達(dá)拉濱磷酸鹽EP雜質(zhì)B |
149297-79-0 |
詳細(xì)
|
| Fludarabine Phosphate EP Impurity F |
氟達(dá)拉濱磷酸鹽EP雜質(zhì)F |
159002-28-5 |
詳細(xì)
|
| Glycopyrronium impurity H |
格隆溴銨雜質(zhì)H |
15206-55-0 |
詳細(xì)
|
| Glycopyrronium impurity K |
格隆溴銨雜質(zhì)K |
3900-93-4 |
詳細(xì)
|
| Glycopyrronium impurity M |
格隆溴銨雜質(zhì)M |
5422-88-8 |
詳細(xì)
|
| Glycyrrhizic Acid (Glycyrrhizin) |
甘草酸 |
1405-86-3 |
詳細(xì)
|
| Hydroxy Donepezi;2,3-Dihydro-2-[hydroxy[1-(phenylmethyl)-4-piperidinyl]methyl]-5,6-dimethoxy-1H-inden-1-one; 2-[(1-Benzylpiperidin-4-yl)hydroxymethyl]-5,6-dimethoxyindan-1-one; |
多奈哌齊羥基雜質(zhì) |
197010-20-1 |
詳細(xì)
|
| Ibuprofen EP Impurity K |
布洛芬EP雜質(zhì)K |
43153-07-7 |
詳細(xì)
|
| Irbesartan Impurity 7 |
厄貝沙坦雜質(zhì)7 |
141745-71-3 |
詳細(xì)
|
| Isopropyl 4-methylbenzenesulfonate; propan-2-yl 4-methylbenzenesulfonate; Benzenesulfonic acid, 4-methyl-, 1-methylethyl ester; Isopropyl p-toluenesulfonate; Isopropyl p-tosylate; |
對(duì)甲苯磺酸異丙酯 |
2307-69-9 |
詳細(xì)
|
| Lansoprazole EP Impurity A ;Lansoprazole N-Oxide |
蘭索拉唑EP雜質(zhì)A;蘭索拉唑N-氧化物 |
213476-12-1 |
詳細(xì)
|
| Lansoprazole EP Impurity B ;Lansoprazole Sulfone |
蘭索拉唑EP雜質(zhì)B;蘭索拉唑砜 |
131926-99-3 |
詳細(xì)
|
| Lansoprazole EP Impurity C |
蘭索拉唑EP雜質(zhì)C |
103577-40-8 |
詳細(xì)
|
| Rabeprazole Impurity C |
雷貝拉唑雜質(zhì)C |
168167-42-8 |
詳細(xì)
|
| Linezolid Diphthalimide;2,2'-(3,3'-(3-Fluoro-4-morpholinophenylazanediyl)bis(2-hydroxypropane-3,1-diyl))diidoindoline-1,3-dione |
利奈唑胺雜質(zhì)16 |
1798014-14-8 |
詳細(xì)
|
| Meloxicam Impurity E |
美洛昔康雜質(zhì)E |
35511-15-0 |
詳細(xì)
|
| Meloxicam Related Compound A |
美洛昔康相關(guān)化合物A |
24683-26-9 |
詳細(xì)
|
| Meloxicam Related Compound B |
美洛昔康相關(guān)化合物B |
7305-71-7 |
詳細(xì)
|
| N-[(1-Methyl-1H-benzimidazol-5-yl)carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester formate |
達(dá)比加群酯雜質(zhì)CDBA468 |
|
詳細(xì)
|
| N-[3-chloro-2-(R)-hydroxypropyl]-3-fluoro-4-(morpholin-4-yl)aniline |
利奈唑胺雜質(zhì)8 |
868405-66-7 |
詳細(xì)
|
| N-Butyryl-4-(5-methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide |
帕瑞昔布鈉雜質(zhì)D |
198470-92-7 |
詳細(xì)
|
| Olmesartan Acid |
奧美沙坦酸 |
144689-24-7 |
詳細(xì)
|
| Olmesartan Medoxomil EP Impurity C |
奧美沙坦酯雜質(zhì)C |
879562-26-2 |
詳細(xì)
|
| Omeprazole EP Impurity B |
奧美拉唑EP雜質(zhì)B |
110374-16-8 |
詳細(xì)
|
| Omeprazole Impurity H215/01 |
奧美拉唑雜質(zhì)H215 /01 |
301669-82-9 |
詳細(xì)
|
| Omeprazole Related Compound 6 |
奧美拉唑相關(guān)化合物6 |
86604-80-0 |
詳細(xì)
|
| ortho-Hydroxy Atorvastatin Calcium Salt |
鄰羥基阿托伐他汀鈣鹽 |
265989-46-6 |
詳細(xì)
|
| para-Hydroxy Atorvastatin Calcium Salt |
對(duì)羥基阿托伐他汀鈣鹽 |
265989-44-4 |
詳細(xì)
|
| Quetiapine EP Impurity H;2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol N-oxide |
喹硫平雜質(zhì)H |
1076199-40-0 |
詳細(xì)
|
| Cinchocaine EP Impurity D;2-Butoxy-4-quinolinecarboxylic Acid; 2-Butoxy-cinchoninic Acid |
辛可卡因雜質(zhì)D |
10222-61-4 |
詳細(xì)
|
| Donepezil Deoxy Impurity |
多奈哌齊脫氧雜質(zhì) |
844694-84-4 |
詳細(xì)
|
| Quetiapine EP Impurity P;Quetiapine N-Ethyl Impurity;11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine hydrochloride |
喹硫平雜質(zhì)P |
1011758-03-4 |
詳細(xì)
|
| Quetiapine EP Impurity W;O-Dibenzo[b,f][1,4]thiazepinyl Quetiapine;11-(2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethoxy) dibenzo[b,f][1,4]thiazepine |
喹硫平EP雜質(zhì)W |
1800608-95-0 |
詳細(xì)
|
| Rabeprazole EP Impurity D |
雷貝拉唑EP雜質(zhì)D |
924663-38-7 |
詳細(xì)
|
| Rabeprazole EP Impurity E |
雷貝拉唑EP雜質(zhì)E |
102804-77-3 |
詳細(xì)
|
| Rabeprazole Related Compound A |
雷貝拉唑相關(guān)化合物A |
1163685-30-0 |
詳細(xì)
|
| Rabeprazole Sulfide |
雷貝拉唑硫化物 |
117977-21-6 |
詳細(xì)
|
| Rapamycin ;Sirolimus |
雷帕霉素;西羅莫司 |
53123-88-9 |
詳細(xì)
|
| Rivaroxaban Diamine Impurity |
利伐沙班二胺雜質(zhì) |
1807455-76-0 |
詳細(xì)
|
| Rivaroxaban Impurity 1 |
利伐沙班雜質(zhì)1 |
721401-53-2 |
詳細(xì)
|
| Rivaroxaban ImpVI |
利伐沙班雜質(zhì)VI |
446292-08-6 |
詳細(xì)
|
| Rivaroxaban Triamine Impurity |
利伐沙班三胺雜質(zhì) |
1632463-24-1 |
詳細(xì)
|
| Tacrolimus |
他克莫司 |
104987-11-3 |
詳細(xì)
|
| brevifolin carboxylic acid;brevifolincarboxylic acid |
短葉蘇木酚酸 |
18490-95-4 |
詳細(xì)
|
| Rebeprazole sulfone N-oxide |
Rabeprazole EP Impurity I(灰色) |
924663-37-6 |
詳細(xì)
|
| (1R,2R)-2-(3,4-difluorophenyl)cyclopropanecarbonyl azide |
替卡格雷疊氮物 |
378236-67-0 |
詳細(xì)
|
| (2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol 2-Acetate; (2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol Acetate (Ester) |
利奈唑胺雜質(zhì)7 |
|
詳細(xì)
|
| (2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol hydrochloride |
利奈唑胺雜質(zhì)17 |
333753-72-3 |
詳細(xì)
|
| (3R,4R,5R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-5-((R)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol |
達(dá)格列凈呋喃環(huán)雜質(zhì) |
1469910-83-5 |
詳細(xì)
|
| (R)-3-methyl-1-((S)-3-phenyl-2-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)propanamido)butylboronic acid |
硼替佐米USP雜質(zhì)O |
1194235-41-0 |
詳細(xì)
|
| (S)-3-phenyl-2-(pyrazine-2-carboxamido)propanoic acid |
硼替佐米USP雜質(zhì)D |
114457-94-2 |
詳細(xì)
|
| (S)-N-(3-chloro-2-hydroxy-1-propyl)acetamide |
利奈唑胺雜質(zhì)19 |
224323-47-1 |
詳細(xì)
|
| 1,1,2-Triethoxy-ethane |
乙氧基乙醛二乙基乙縮醛 |
4819-77-6 |
詳細(xì)
|
| 11,11'-(1,4-Piperazinediyl)bis-dibenzo[b,f][1,4]thiazepine; Quetiapine EP Impurity D;Quetiapine Dimer Impurity |
喹硫平雜質(zhì)D |
945668-94-0 |
詳細(xì)
|
| 2-[(2S)-3-Chloro-2-hydroxypropyl]-1H-isoindole-1,3(2H)-dione |
利伐沙班雜質(zhì) |
148857-42-5 |
詳細(xì)
|
| 2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethanol; Quetiapine EP Impurity I; |
喹硫平雜質(zhì)I |
329216-67-3 |
詳細(xì)
|
| 2-{2-[2-(3-Methoxy-phenyl)-ethyl]-phenoxymethyl}-oxirane |
沙格雷酯雜質(zhì)2 |
1140968-46-2 |
詳細(xì)
|
| 2-hydroxy-cinchoninic Acid; 1,2-Dihydro-2-oxo-4-Cinchocaine EP Impurity B;quinolinecarboxylic Acid; 2-Hydroxy-4-quinolinecarboxylic Acid; 2-Hydroxycinchoninic Acid; 2-Hydroxyquinoline-4-carboxylic Acid; 4-Carboxycarbostyril; |
辛可卡因雜質(zhì)B |
15733-89-8 |
詳細(xì)
|
| 3-[2-[4-(4-Fluoro-2-hydroxybenzoyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one |
帕潘立酮棕櫚酸酯開環(huán)雜質(zhì) |
152542-03-5 |
詳細(xì)
|
| 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-7,8-dihydro-2-methyl-4H-pyrido[1,2-a]pyrimidine-4,9(6H)-dione |
帕潘立酮棕櫚酸酯氧化雜質(zhì) |
1189516-65-1 |
詳細(xì)
|
| 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one Hydrochloride; 6,7,8,9-Dehydro 9-Hydroxy Risperidone Hydrochloride |
帕潘立酮棕櫚酸酯P3加氫不完全雜質(zhì) |
170359-61-2 |
詳細(xì)
|
| 3-methyl-4,5-diphenylisoxazole |
帕瑞昔布雜質(zhì)I |
75115-00-3 |
詳細(xì)
|
| 4-methylbenzenesulfonamide; p-Toluenesulfonamide; |
對(duì)甲苯磺酰胺 |
70-55-3 |
詳細(xì)
|
| 5-[2-[5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carbonyl]oxypropan-2-yl]-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid |
奧美沙坦酯二聚體雜質(zhì) |
1040250-19-8 |
詳細(xì)
|
| 9-[(2S)-2-(diethoxyphosphorylmethoxy)propyl]purin-6-amine |
替諾福韋二乙酯 |
180587-75-1 |
詳細(xì)
|
| Acetic propionic anhydride;acetyl propanoate |
乙酸丙酸酐 |
13080-96-1 |
詳細(xì)
|
| Baccatin III |
巴卡丁 III |
27548-93-2 |
詳細(xì)
|
| Betahistine EP Impurity C TriHCl |
鹽酸倍他司汀EP雜質(zhì)C |
|
詳細(xì)
|
| Bortezomib USP Related Compoud B;N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide |
硼替佐米USP雜質(zhì)B |
289472-80-6 |
詳細(xì)
|
| Bortezomib USP Related Compoud H;(1R,2R)-Bortezomib;B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid; [(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid |
硼替佐米USP雜質(zhì)H |
1132709-15-9 |
詳細(xì)
|
| Bortezomib USP Related Compoud I;(R)-Hydroxy Des(boric Acid) Bortezomib;N-[(1S)-2-[[(1R)-1-Hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide; N-[(1S)-2-[[(1R)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]pyrazin |
硼替佐米USP雜質(zhì)I |
289472-78-2 |
詳細(xì)
|
| Bortezomib USP Related Compoud J;(S)-Hydroxy Des(boric Acid) Bortezomib;N-[(1S)-2-[[(1S)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-2-Pyrazinecarboxamide; N-[(1S)-2-[[(1S)-1-hydroxy-3-methylbutyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-pyrazi |
硼替佐米USP雜質(zhì)J |
289472-81-7 |
詳細(xì)
|
| Bortezomib USP Related Compoud L;(R)-Hydroperoxy Des(boric Acid) Bortezomib;N-((S)-1-(((R)-1-Hydroperoxy-3-methylbutyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
硼替佐米USP雜質(zhì)L |
886979-78-8 |
詳細(xì)
|
| Bortezomib USP Related Compoud M;(S)-Hydroperoxy Des(boric Acid) Bortezomib;N-((S)-1-(((S)-1-Hydroperoxy-3-methylbutyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
硼替佐米USP雜質(zhì)M |
886979-81-3 |
詳細(xì)
|
| Rivaroxaban ImpIII |
利伐沙班雜質(zhì)III-脫氧化合物 |
1415566-28-7 |
詳細(xì)
|
| Rivaroxaban ImpIV |
利伐沙班雜質(zhì)IV |
1770812-37-7 |
詳細(xì)
|
| Sitagliptin Deamino Impurity 2 (Mixture of Z and E Isomers);3-Desamino-3,4-dehydro Sitagliptin;(E)-1-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-3-en-1-one |
西格列汀FP雜質(zhì)C |
1675201-14-5 |
詳細(xì)
|
| Succinic acid mono-(1-dimethylaminomethyl-2-{2-[2-(3-methoxy-phenyl)-vinyl]-phenoxy}-ethyl) ester |
沙格雷酯雜質(zhì)1 |
1659311-42-8 |
詳細(xì)
|